|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online November 8, 2006
doi: 10.1242/10.1242/jcs.03266
Commentary |
Cancer Research UK Stress Response Laboratory, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK
* Author for correspondence (e-mail: Stephen.Keyse{at}cancer.org.uk)
Accepted 19 September 2006
A structurally distinct subfamily of ten dual-specificity (Thr/Tyr) protein phosphatases is responsible for the regulated dephosphorylation and inactivation of mitogen-activated protein kinase (MAPK) family members in mammals. These MAPK phosphatases (MKPs) interact specifically with their substrates through a modular kinase-interaction motif (KIM) located within the N-terminal non-catalytic domain of the protein. In addition, MAPK binding is often accompanied by enzymatic activation of the C-terminal catalytic domain, thus ensuring specificity of action. Despite our knowledge of the biochemical and structural basis for the catalytic mechanism of the MKPs, we know much less about their regulation and physiological functions in mammalian cells and tissues. However, recent studies employing a range of model systems have begun to reveal essential non-redundant roles for the MKPs in determining the outcome of MAPK signalling in a variety of physiological contexts. These include development, immune system function, metabolic homeostasis and the regulation of cellular stress responses. Interestingly, these functions may reflect both restricted subcellular MKP activity and changes in the levels of signalling through multiple MAPK pathways.
Key words: MAPK, MKP, Signal transduction, Phosphorylation
This article has been cited by other articles:
|
|
 |
|
  R. Furst, S. Zahler, and A. M. Vollmar Dexamethasone-Induced Expression of Endothelial Mitogen-Activated Protein Kinase Phosphatase-1 Involves Activation of the Transcription Factors Activator Protein-1 and 3',5'-Cyclic Adenosine 5'-Monophosphate Response Element-Binding Protein and the Generation of Reactive Oxygen Species Endocrinology, July 1, 2008; 149(7): 3635 - 3642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. V. Mortensen, M. B. Larsen, B. M. Prasad, and S. G. Amara Genetic Complementation Screen Identifies a Mitogen-activated Protein Kinase Phosphatase, MKP3, as a Regulator of Dopamine Transporter Trafficking Mol. Biol. Cell, July 1, 2008; 19(7): 2818 - 2829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Lomonaco, S. Kahana, M. Blass, Y. Brody, H. Okhrimenko, C. Xiang, S. Finniss, P. M. Blumberg, H.-K. Lee, and C. Brodie Phosphorylation of Protein Kinase C{delta} on Distinct Tyrosine Residues Induces Sustained Activation of Erk1/2 via Down-regulation of MKP-1: ROLE IN THE APOPTOTIC EFFECT OF ETOPOSIDE J. Biol. Chem., June 20, 2008; 283(25): 17731 - 17739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Callejas-Valera, J. Guinea-Viniegra, C. Ramirez-Castillejo, J. A. Recio, E. Galan-Moya, N. Martinez, J. M. Rojas, S. R. y Cajal, and R. Sanchez-Prieto E1a Gene Expression Blocks the ERK1/2 Signaling Pathway by Promoting Nuclear Localization and MKP Up-regulation: IMPLICATION IN v-H-Ras-INDUCED SENESCENCE J. Biol. Chem., May 9, 2008; 283(19): 13450 - 13458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Przyklenk, M. Maynard, C. E. Darling, and P. Whittaker Aging Mouse Hearts Are Refractory to Infarct Size Reduction With Post-Conditioning J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1393 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hou, S. Torii, N. Saito, M. Hosaka, and T. Takeuchi Reactive Oxygen Species-Mediated Pancreatic {beta}-Cell Death Is Regulated by Interactions between Stress-Activated Protein Kinases, p38 and c-Jun N-Terminal Kinase, and Mitogen-Activated Protein Kinase Phosphatases Endocrinology, April 1, 2008; 149(4): 1654 - 1665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wang, J.-Y. Zhou, and G. S. Wu ERK-Dependent MKP-1 Mediated Cisplatin Resistance in Human Ovarian Cancer Cells Cancer Res., December 15, 2007; 67(24): 11933 - 11941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu, J. Lagowski, A. Sundholm, A. Sundberg, and M. Kulesz-Martin Microtubule Disruption and Tumor Suppression by Mitogen-Activated Protein Kinase Phosphatase 4 Cancer Res., November 15, 2007; 67(22): 10711 - 10719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. V. Maier, S. Brema, J. Tuckermann, U. Herzer, M. Klein, M. Stassen, A. Moorthy, and A. C. B. Cato Dual Specificity Phosphatase 1 Knockout Mice Show Enhanced Susceptibility to Anaphylaxis but Are Sensitive to Glucocorticoids Mol. Endocrinol., November 1, 2007; 21(11): 2663 - 2671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Lee and B. E. Ellis Arabidopsis MAPK Phosphatase 2 (MKP2) Positively Regulates Oxidative Stress Tolerance and Inactivates the MPK3 and MPK6 MAPKs J. Biol. Chem., August 24, 2007; 282(34): 25020 - 25029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wang, W. H. Shen, Y. J. Jin, P. W. Brandt-Rauf, and Y. Yin A Molecular Link between E2F-1 and the MAPK Cascade J. Biol. Chem., June 22, 2007; 282(25): 18521 - 18531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Tao and L. Tong Crystal structure of the MAP kinase binding domain and the catalytic domain of human MKP5 Protein Sci., May 1, 2007; 16(5): 880 - 886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tu, W. Wu, T. Wu, Z. Cao, R. Wilkins, B.-H. Toh, M. E. Cooper, and Z. Chai Antiproliferative Autoantigen CDA1 Transcriptionally Up-regulates p21Waf1/Cip1 by Activating p53 and MEK/ERK1/2 MAPK Pathways J. Biol. Chem., April 20, 2007; 282(16): 11722 - 11731. [Abstract] [Full Text] [PDF]
|
|
